FDA Commissioner Dr. Marty Makary tells CBS News' Norah O'Donnell in an exclusive interview why the agency decided to drop decades-old "black box" warnings on many hormone therapy drugs used for ...

Ibrahim also elaborated on her efforts to harmonise generic drugs’ regulations in order to ensure the provision of high standard and affordable drugs — a matter that saves billions of dollars annually ...

Vice President Kamala Harris butchered the name for the FDA in an interview about abortion rights that aired Friday. Harris mistakenly said the Federal Drug Administration approved the abortion pill ...

In an interview yesterday, the FDA made some potentially controversial and confusing statements about consumer genetics, an area it's in the process of deciding how to regulate. I criticize the agency ...

Dr. David Acheson took on the newly created position of assistant commissioner of food protection at the Food and Drug Administration last month. He was previously the director of the FDA's Office of ...

The FDA appointed George Tidmarsh, MD, PhD, to be the nation's top drug official in July. The Center for Drug Evaluation and ...

In early June 2011, the US Food and Drug Administration (FDA) issued a drug safety communication on the 80-mg dose of simvastatin because of an increased risk for muscle toxicity. Medscape interviewed ...

Hamburg downplayed suggestions that the agency might remove a heavily criticized painkiller from the market if a harder-to-abuse version becomes available. She said better abuse-deterrent formulas are ...

Medscape: Is the FDA concerned about shortages of influenza vaccine? What efforts are being made to address actual shortages and those resulting from uneven distribution? Should clinicians prioritize ...

Last week Margaret Hamburg took time out during a health care summit at the Cleveland Clinic in Ohio to talk to me about finding more money for the agency, making it tougher and stronger, and ...

When the Food and Drug Administration lifted some — but not all — of its restrictions on an abortion pill this week, it raised questions about why these rules were there in the first place.

In an exclusive interview with Sarah Ibrahim — associate director for Global Generic Drug Affairs at the US Food and Drug Administration (FDA) and the first Egyptian-American in such a leading ...